Minister of Health Terrence Deyalsingh is defending the ministry’s strategy for acquiring monkeypox vaccines, after opposition MP Dr Rishad Seecharan said other non-World Health Organisation (WHO) avenues should be explored.
Speaking at the ministry’s COVID-19 virtual press conference yesterday, Deyalsingh said such a move is not possible.
“There is one manufacturer in the world (of monkeypox vaccines) called Bavarian Nordic. PAHO (Pan American Health Organisation) has been appointed, these are my words, the agent for the PAHO region and PAHO, by resolution, has indicated that they will be dealing with this lone manufacturer,” he said.
T&T has ordered 2,000 doses of monkeypox vaccines with an indicative order through PAHO.
Deyalsingh said the opposition’s statements on the matter were misleading the public. He said if they wish to assist the country in acquiring the vaccines, they can join him in appealing to larger countries for doses.
Acquiring monkeypox vaccines has encountered a similar problem to those experienced when doses for COVID-19 were just developed - large countries are buying them up and creating difficulties for smaller nations to acquire them.
While there is still no news on when and at what cost T&T will receive its monkeypox doses, Deyalsingh said they were able to find out the shelf life of the doses. He said this ranges between three years if stored at -20 degrees or five years if stored at -50 degrees. Deyalsingh said T&T has the capacity to store it at the lower temperature to keep the doses longer.
He said the exact expiration date of doses coming to T&T will be determined when the contract is signed.
On Sunday, Dr Seecharan called on Deyalsingh to explore other options for acquiring the vaccines, criticising the ministry for its heavy reliance on WHO platforms. He cited the difficulties in acquiring doses through platforms such as COVAX during the COVID-19 pandemic. He suggested diplomatic channels also be explored to have doses donated to T&T.